Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
70598-03-7
956935-28-7
926213-17-4
1343894-50-7
1432679-18-9
1052539-34-0 | 1-{[4-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-5-amine hydrochloride | AA019OSG | MFCD07689444
69145-57-9 | 2-{[(propan-2-yl)carbamoyl]amino}benzoic acid | AA019P1W | MFCD00248827
51871-17-1 | propan-2-yl 3-aminopropanoate hydrochloride | AA019P96 | MFCD08457600
940271-56-7 | 1-(Chloroacetyl)-5-(2-methyl-1,3-thiazol-4-yl)indoline | AA019PFV | MFCD09389741
905009-15-6 | methyl 2-(2-chloroacetamido)-4-(2-chlorophenyl)thiophene-3-carboxylate | AA019PLP | MFCD02853978
355809-32-4 | 2-[(4-carbamoylphenyl)amino]acetic acid | AA019PQN | MFCD00461104
1293039-30-1 | 3-[(5-Bromothiophen-3-yl)methoxy]-4-methylbenzoic acid | AA019QIV | MFCD13473854
1087798-27-3 | 2,2,2-trifluoroethyl N-[4-(propan-2-yl)phenyl]carbamate | AA019QS8 | MFCD11099853
131864-73-8 | (2S)-1-(2-methoxyphenyl)propan-2-ol | AA019R5P | MFCD14705960
1354963-40-8 | [4-(4-fluorophenyl)-1H-imidazol-2-yl]methanamine dihydrochloride | AA019RNR | MFCD14635987
Journal: Bioorganic & medicinal chemistry letters20101101